• Publications
  • Influence
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.
PURPOSE To investigate the prognostic value of BRAF V600E mutation for the recurrence of papillary thyroid cancer (PTC). PATIENTS AND METHODS This was a retrospective multicenter study of theExpand
  • 309
  • 19
Surgical trends in the management of thyroid lymphoma.
AIMS To determine the changing trends and current role of surgery for the management of thyroid lymphoma. METHODS A retrospective review of 50 surgical patients with a final diagnosis of thyroidExpand
  • 35
  • 19
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
IMPORTANCE BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PTC-related patient mortality has not been established. OBJECTIVE To investigate the relationshipExpand
  • 605
  • 14
  • PDF
Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types
The Carney triad (CT) is gastrointestinal stromal tumor (GIST), paraganglioma, and pulmonary chondroma. The GISTs of CT show different clinical, molecular, and morphologic features to usual adultExpand
  • 165
  • 13
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
BACKGROUND Lymphadenectomy in clinically node-negative papillary thyroid cancer (PTC) is controversial. The aim of this study is to determine whether routine ipsilateral level VI lymphadenectomyExpand
  • 331
  • 12
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Purpose: Adrenocortical adenomas are common, whereas adrenocortical carcinomas are rare. Discriminating between benign and malignant adrenocortical tumors using conventional histology can beExpand
  • 220
  • 12
  • PDF
A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
Pathogenic ALK translocations have been reported in papillary thyroid carcinoma (PTC). We developed and validated a screening algorithm based on immunohistochemistry (IHC), followed by fluorescenceExpand
  • 55
  • 9
Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion.
INTRODUCTION Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodalityExpand
  • 84
  • 8
MicroRNA‐222 and MicroRNA‐146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer
Papillary thyroid cancer (PTC) persistence or recurrence and the need for long‐term surveillance can cause significant inconvenience and morbidity in patients. Currently, recurrence riskExpand
  • 112
  • 7
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
CONTEXT Individualized management, incorporating papillary thyroid cancer (PTC) variant-specific risk, is conceivably a useful treatment strategy for PTC, which awaits comprehensive dataExpand
  • 118
  • 5